Brief: Amneal Receives U.S. FDA Approval For Albuterol Sulfate Inhalation Aerosol
02/12/2025 13:50
Dec 2 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL RECEIVES U.S. FDA APPROVAL FOR ALBUTEROL SULFATE INHALATION AEROSOL Source text: ID:nGNX4xm3LF Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta